| Discovery of 9-(1-phenoxyethyl)-2-morpholino-4-oxo-pyrido [1, 2-a] pyrimidine-7-carboxamides as oral PI3Kβ inhibitors, useful as antiplatelet agents F Giordanetto, B Barlaam, S Berglund, K Edman, O Karlsson, J Lindberg, ... Bioorganic & medicinal chemistry letters 24 (16), 3936-3943, 2014 | 31 | 2014 |
| Parallel and modular synthesis of P-chirogenic P, O-ligands MJ Johansson, S Berglund, Y Hu, KHO Andersson, N Kann ACS combinatorial science 14 (5), 304-308, 2012 | 18 | 2012 |
| Characterization of selective and potent JAK1 inhibitors intended for the inhaled treatment of asthma M Nilsson, M Rhedin, R Hendrickx, S Berglund, A Piras, P Blomgran, ... Drug Design, Development and Therapy, 2901-2917, 2022 | 17 | 2022 |
| Optimization of piperidin-4-yl-urea-containing melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Reducing hERG-associated liabilities S Berglund, BJ Egner, H Gradén, J Gradén, DGA Morgan, T Inghardt, ... Bioorganic & medicinal chemistry letters 19 (15), 4274-4279, 2009 | 15 | 2009 |
| Discovery of 1, 3-disubstituted-1H-pyrrole derivatives as potent Melanin-Concentrating Hormone Receptor 1 (MCH-R1) antagonists S Berglund, BJ Egner, H Gradén, J Gradén, DGA Morgan, T Inghardt, ... Bioorganic & medicinal chemistry letters 18 (17), 4859-4863, 2008 | 13 | 2008 |
| Optimization of 2-piperidin-4-yl-acetamides as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Designing out hERG inhibition S Berglund, BJ Egner, H Gradén, J Gradén, DGA Morgan, T Inghardt, ... Bioorganic & medicinal chemistry letters 19 (15), 4268-4273, 2009 | 12 | 2009 |
| Discovery of the Potent and Selective Inhaled Janus Kinase 1 Inhibitor AZD4604 and Its Preclinical Characterization M Nilsson, K Berggren, S Berglund, S Cerboni, M Collins, G Dahl, ... Journal of Medicinal Chemistry, 2023 | 3 | 2023 |
